site stats

Crsp analyst ratings

Web7 rows · Apr 6, 2024 · Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 ... WebApr 10, 2024 · According to 33 stock analysts, the average 12-month stock price forecast for CRSP stock is $ 88.13 , which predicts an increase of 94.85%. The lowest target is $ 39.39 and the highest is $ 231. On average, analysts rate CRSP stock as a buy. Analyst Consensus: Buy Analyst Ratings

CRISPR Therapeutics Stock (NASDAQ:CRSP), Analyst …

WebApr 14, 2024 · InvestorsObserver is giving Crispr Therapeutics AG (CRSP) an Analyst Rating Rank of 33, meaning CRSP is ranked higher by analysts than 33% of stocks. … Web2 days ago · The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 105.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ... davidson college biology major https://detailxpertspugetsound.com

CRSP CRISPR Therapeutics AG Analyst Estimates MarketWatch

WebApr 13, 2024 · Shares of CRISPR Therapeutics AG ( NASDAQ:CRSP - Get Rating) have received a consensus rating of "Hold" from the twenty analysts that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. Web23 hours ago · The analyst sees a lot of momentum to come back into this stock, starting with the ongoing exa-cel regulatory review. Price Action: CRSP shares are up 15.50% at $50.22 on the last check Thursday. WebCRSP will report Q1 2024 earnings on 05/09/2024 EPS Surprise Estimate Actual Q1 2024 Q2 2024 Q3 2024 Q4 2024 -3 -2 -1 Analyst Ratings Upgrades/Downgrades View All Upgrades & Downgrades FY... gastonia north carolina building permits

CRISPR stock jumps as Cantor issues bullish view (NASDAQ:CRSP)

Category:Crispr Therapeutics AG (CRSP) Stock: Do Analysts Think You …

Tags:Crsp analyst ratings

Crsp analyst ratings

Analyst Ratings for CRISPR Therapeutics Markets Insider

WebCRSP Analyst Ratings Moderate Buy 17 Ratings 9 Buy 7 Hold 1 Sell Based on 17 analysts giving stock ratings to Crispr Therapeutics AG in the past 3 months CRSP … WebApr 14, 2024 · InvestorsObserver is giving Crispr Therapeutics AG (CRSP) an Analyst Rating Rank of 33, meaning CRSP is ranked higher by analysts than 33% of stocks. The average price target for CRSP is $87.24 and analyst’s rate the stock as a Buy. Wall Street analysts are rating CRSP a Buy today. Find out what this means to you and get the rest …

Crsp analyst ratings

Did you know?

WebApr 13, 2024 · Get Wall Street analysts ratings for CRISPR Therapeutics AG (CRSP). Buy or Sell this stock? See what the analysts say. WebCRISPR Therapeutics AG research and ratings by Barron's. View CRSP revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

WebApr 13, 2024 · Shares of CRISPR Therapeutics AG ( NASDAQ:CRSP - Get Rating) have received a consensus rating of "Hold" from the twenty analysts that are presently … Web1 day ago · Upgrades. UBS upgraded the previous rating for Ingredion Inc INGR from Neutral to Buy. For the fourth quarter, Ingredion had an EPS of $1.65, compared to year-ago quarter EPS of $1.09.

WebAnalyst Ratings Average price target from 28 ratings: $ 86.40 Average score: Sell Under Hold Over Buy Full Ratings Open $45.63 Previous Close- YTD Change 12.52% 12 Month Change -32.63% Day...

Web1 day ago · Although CRSP has traded at a recent price of $43.47/share, the average analyst target is 100.69% higher at $87.24/share. Similarly, VCYT has 44.87% upside from the recent share price of $21.26 if ...

Web23 hours ago · Cantor Fitzgerald initiated coverage on CRISPR Therapeutics AG (NASDAQ:CRSP) with an Overweight rating and a price target of $72, citing an interesting gene editing play for 2024. The company... davidson college break scheduleWeb23 hours ago · CRSP +14.8% + Free Alerts with an Overweight rating and a price target of $72, citing an interesting gene editing play for 2024. The company has an excellent … davidson college cost of attendanceWebMay 17, 2024 · Analyst Ratings for CRISPR Therapeutics. Benzinga. May. 17, 2024, 12:03 PM. Over the past 3 months, 11 analysts have published their opinion on CRISPR … gastonian hotel charleston scWebCRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations. ... Number Of Ratings: 27: FY Report Date: 12/2024: … davidson college cross country menWeb1 day ago · CRISPR Therapeutics (CRSP) jumped Thursday after Cantor Fitzgerald launched its coverage with an Overweight rating and a $72 per share target. Find out the reasons. gastonia north carolina historyWeb2 days ago · View real-time CRSP stock price and news, along with industry-best analysis. ... Analyst Ratings. Average price target from 29 ratings: $78.76. ... Fundamental … gastonia north carolina airbnbWebApr 13, 2024 · Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, CRISPR Therapeutics has a consensus rating of “Hold” and a consensus target price of $72.84. CRISPR Therapeutics Profile ( Get Rating) gastonia north carolina inmate search